TABLE 2.

Percentage of patients with each diagnosis receiving TPE and duration of TPE in standard and rapid turnaround time (TAT) scenarios for each country^*

Diagnoses	US		UK		France
	Standard TAT scenario	Rapid TAT scenario	Standard TAT scenario	Rapid TAT scenario	Standard TAT scenario	Rapid TAT scenario
TTP	100%, 3 days	100%, 3 days	100%, 3 days	100%, 3 days	100%, 3 days	100%, 3 days
aHUS	100%, 3 days	10.3%, 3 days	100%, 3 days	50%, 3 days	100%, 3 days	100%, 3 days
STEC‐HUS	100%, 2 days	10.3%, 2 days	100%, 2 days	50%, 2 days	100%, 3 days	100%, 3 days
Other diagnoses	100%, 3 days	5%, 3 days	100%, 3 days	0%, 0 days	100%, 3 days	10%, 3 days

Abbreviations: aHUS, atypical (complement‐mediated) hemolytic uremic syndrome; STEC‐HUS, Shiga toxin–producing Escherichia coli–associated hemolytic uremic syndrome; TAT, turnaround time; TPE, therapeutic plasma exchange; TTP, thrombotic thrombocytopenic purpura.

^*Assumptions based on guidelines ¹ , ¹⁰ , ¹¹ and expert opinion.